Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized polymyxin therapy modeling in critically ill patients with intracranial infection
ChiCTR2500104126Phase 4Recruiting
- Sponsor
- Hainan People's Hospital
- Start
- Jun 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polymyxin B in intracranial infection and Gram-negative bacterial infection, sponsored by Hainan People's Hospital. Primary endpoints: Blood concentration and Drug clearance. Started Jun 2025; status: recruiting.
02
Drugs
polymyxin B
03
Conditions
intracranial infectionGram-negative bacterial infection
Beyond the preview
Go deeper on ChiCTR2500104126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104126.